Cite Filings / KLRS / 0000899243-21-006016
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
5

Annual Insider Trading Report

Kalaris Therapeutics, Inc. · Filed 2021-02-11 · Acc 0000899243-21-006016

Documents 1

  • 5 Annual Insider Trading Report , xslF345X03/doc5.xml

Around this filing

  • 2021-02-12 10-K Annual Report
  • 2021-02-12 S-8 Securities Offered to Employees in Benefit Plans
  • 2021-02-11 8-K Results of operations
  • 2021-02-11 5 Annual Insider Trading Report
  • 2021-02-08 SC 13G/A Amended Statement of Ownership
  • 2021-02-04 4 Chief Medical Officer sold 54,849 shares at $41.19 ($2,259,230)
  • 2021-02-04 4 Chief Commercial Officer sold 48,910 shares at $41.19 ($2,014,603)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslF345X03/doc5.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…